Cyclosporin A monitoring by 2-h levels: Preliminary target levels in stable pediatric kidney transplant recipients

Clinical Transplantation

Volumn 17, Issue 6, 2003, Pages 546-548

  Pape, Lars ^a   Lehnhardt, A ^a   Latta, K ^a   Ehrich, J H H ^a   Offner, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C2 monitoring; Pediatric kidney transplantation

Indexed keywords

CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CHI SQUARE TEST; CHILD; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PEDIATRICS; PRIORITY JOURNAL; RANK SUM TEST; RECIPIENT; TREATMENT OUTCOME;

CHILD; CYCLOSPORINE; DRUG MONITORING; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 0344466591     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0012.2003.00107.x     Document Type: Article

References (19)

1. Cole E, Midtvendt K, Johnston A, Pattison J, O'Grady C. Recommendations for the implementation of Neoral C2-monitoring in clinical practice. Transplantation 2002: 73: S19.
2. Mahalati K, Belitsky P, West K et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 2001: 12: 823.
3. Keshavamurthy M, Al Ahmadi I, Maohammed RS. Single-centre study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with Neoral. Transplant Proc 2001: 33: 3098.
4. Maham N, Cardella C, Cole E. Optimization of cyclosporine exposure utilizing C2-level monitoring in de novo renal transplant recipients. Transplant Proc 2001: 33: 2098.
5. Canadian Neoral Renal Transplantation Study Group. Absorption profile of cyclosporine microemulsion (Neoral) during the first two weeks after renal transplantation. Transplantation 2001: 72: 1024.
6. Morris RG, Russ GR, Cervelli MJ, Juneja R, McDonald SP, Mathew TH. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 2002: 24: 479.
7. Levy G, Burra P, Cavallari A et al. Improved clinical outcome for liver transplant recipients using cylosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 2002: 73: 953.
8. Nashan B, Cole E, Levy G, Thervet E. Clinical validation studies of Neoral C2 monitoring. A review. Transplantation 2002: 73: S3.
9. Levy G, Thervet E, Lake J, Uchida K. Patient management by Neoral C2 monitoring: an international consensus statement. Transplantation 2002: 73: S12.
10. Levy G. C2 monitoring strategy for optimizing cyclosporine immunosuppression. BioDrugs 2001: 15: 279.
11. Meier-Kriesche HU, Swinford R, Kahan BD, Brannan P, Portman RJ. Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation. Peditatr Nephrol 2000: 15: 2.
12. Dello Strolongo L, Campagnano P, Federici G, Rizzoni G. Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level. Pediatr Nephrol 1999: 13: 95.
13. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time-curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999: 15: 55.
14. Filler G, Mai I, Filler S, Ehrich JHH. Abbreviated cyclosporine AUCs on Neoral - the search continues. Pediatr Nephrol 1999: 13: 98
15. Meier-Kriesche HU, Bonilla-Felix MA, Ferris ME et al. A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients. Pediatr Nephrol 1999: 13: 742.
16. Hoyer P. Therapeutic drug monitoring of cyclosporine A: should we use the area under the concentration time-curve and forget trough levels? Pediatr Transplant 2000: 4: 2.
17. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987: 34: 571.
18. Collins MH, Montone KT, Leahey AM et al. Posttransplant lymphoproliferative disease in children. Pediatr Transplant 2001: 5: 250.
19. Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination: an appropriate tool to monitor Neoral therapy? Ther Drug Monit 2002: 24: 40.